Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

The global continuous positive airway pressure (CPAP) market is projected to reach a value of USD 900 million by 2033, ...

Researchers, including experts from the University of Missouri School of Medicine, explored the use of senolytics—drugs ...

According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

Pharyngeal pressures in 11 preterm infants, receiving binasal Hudson prong continuous positive airway pressure (CPAP) pressurised by bubbling bottles, were measured. The mean (95% confidence interval) ...

ResMed launches AirSense 11, to advance digital health in sleep apnoea for Indians: Our Bureau, Bengaluru Monday, January 6, 2025, 17:30 Hrs [IST] ResMed, the world’s leading he ...

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

Objective To investigate a method of minimally invasive surfactant therapy (MIST) to be used in spontaneously breathing preterm infants on continuous positive airway pressure (CPAP), evaluating the ...

OSA impacts about 936 million people worldwide and occurs when the throat muscles relax and block the airway with a common ...

RMD's shares gain on the back of robust mask and device sales growth. However, the unfavorable macroeconomic scenario is ...

Sleep apnea, a condition that disrupts breathing during sleep, affects millions of people worldwide, especially adults over ...